Clinical trial
Reversibility of Brain Glucose Transport and Metabolism in T2DM
NCT05776563 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversibility of Brain Glucose Transport and Metabolism in T2DM
- Lead sponsor
- Yale University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 19, 2024
- Completion date
- May 31, 2027
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.